Challenging risk assessment

Forum for Applied Research and Public Policy

Volumn 13, Issue 3, 1998, Pages 11-18

  Vom Saal, Frederick S ^a   Sheehan, Daniel M ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27844449643     PISSN: 08878218     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. F.S vom Saal, "Sexual differentiation in litter bearing mammals: influence of sex of adjacent fetuses in utero," Journal of Animal Science 67 (1989), pp. 1824-1840;
2. F.S. vom Saal et al., "Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses," Proceedings of the National Academy of Science 94 (1997), pp. 2056-2061.
3. T. Colburn and C. Clement, Chemically induced alterations in sexual and functional development: The wildlife/human connection (Princeton, NJ: Princeton Scientific Publishing, 1992);
4. T. Colborn, F.S. vom Saal, and A.M. Soto, "Developmental effects of endocrine disrupting chemicals in wildlife and humans," Environmental Health Perspectives 101 (1993), pp. 378-384.
5. R.J. Kavlock et al., "Research needs for the risk assessment of health and environmental effects of endocrine disrupters: A report of the U.S. EPA-sponsored workshop," Environmental Health Perspectives 104 (1996), pp. 715-740.
6. J. Asby et al., "The challenge posed by endocrine-disrupting chemicals," Environmental Health Perspectives 105 (1997), pp. 164-169
7. J.L. Jacobson and S.W. Jacobson, "Intellectual impairment in children exposed to polychlorinated biphenyls in utero," New England Journal of Medicine 335 (1996), pp. 783-791;
8. E. Lonky et al., "Neonatal behavioral assessment scale performance in humans influenced by maternal consumption of environmentally contaminated Lake Ontario fish," Journal of the Great Lakes Res 22 (1996), pp. 198-212.
9. D.M. Fry and C.K.Toone, "DDT-induced feminization of gull embryos," Science 213 (1981), pp. 922-924;
10. J.L. Jacobson and S.W. Jacobson, "Intellectual impairment in children exposed to polychlorinated biphenyls in utero":
11. Lonky et al., "Neonatal behavioral assessment scale performance;"
12. H.B. Daly et al., "Maternal consumption of Lake Ontario salmon in rats produces behavioral changes in the offspring," Toxicology and Industrial Health 14 (1998), pp. 25-39;
13. F.S. vom Saal et al., "A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior," Toxicology and Industrial Health 14 (1998).
14. Compilation of laws enforced by the U.S. Food and Drug Administration and related statutes, vol. 2 (Washington, DC: U.S. Government Printing Office, 1996);
15. Safe Drinking Water Act amendment of 1996, Public Law 104-182; http://www.epa.gov/watrhome/regs/sdwa.html.
16. Kavlock et al., (1996), "Research needs for the risk assessment of health and environmental effects of endocrine disrupters: A report of the U.S. EPA-sponsored workshop."
17. E.J. Calabrese and L.A. Baldwin, "The dose determines the stimulation (and poison): Development of a chemical hormesis database," International Journal of Toxicology 16 (1997), pp. 545-559.
18. W.R. Kelce et al., "Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist," Nature 375 (1995), pp. 581-585;
19. T. Colborn, M.J. Smolen, and R. Rolland, "Environmental neurotoxic effects: The search for new protocols in functional teratology," Toxicology and Industrial Health 14 (1998), pp. 9-23.
20. vom Saal et al., "Prostate enlargement in mice."
21. Society of the Plastics Industry, "Report on the potential exposures to bisphenol A from epoxy can coatings" (Washington, DC: 1996).
22. S.C. Nagel et al., "Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol," Environmental Health Perspectives 105, pp. 70-76.
23. J.B. Colerangle and D. Roy, "Profound effects of the weak environmental estrogen-like chemical bisphenol A on the growth of the mammary gland of noble rats," Journal of Steroid Biochemistry and Molecular Biology 60, (1997), pp. 153-160;
24. R. Steinmetz et al. "The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo," Endocrinology 138 (1997), pp. 1780-1786.
25. vom Saal et al., "Prostate enlargement in mice."
26. F.S. vom Saal et al., "Estrogenic pesticides: Binding relative to estradiol in MCF-7 cells and effects of exposure during fetal life on subsequent territorial behavior in male mice," Toxicology Letters 77 (1995), pp. 343-350.
27. Calabrese and Baldwin, "The dose determines the stimulation (and poison)."
28. Nagel et al., "Relative binding affinity-serum modified access (RBA-SMA)";
29. W.V. Welshons, F.S. vom Saal, and S.C. Nagel, "Bisphenol A in food cans: An Update," Environmental Health Perspectives 105 (1997), pp. 571-572.
30. vom Saal et al., "Estrogenic pesticides."
31. vom Saal et al., "Prostate enlargement in mice."
32. vom Saal, "Sexual differentiation in litter bearing mammals";
33. M.M. Montano, W.V. Welshons, and F.S. vom Saal, "Free estradiol in serum and brain uptake of estradiol during fetal and neonatal sexual differentiation in female rats," Biology of Reproduction 53 (1995), pp.1198-1207;
34. vom Saal et al., "Prostate enlargement in mice."
35. D.G. Hoel, "Incorporation of background in dose-response models," Federation Proceedings 39 (1980), pp. 73-75;
36. D.W. Gaylor et al., "The threshold dose question in teratogenesis," Teratology 38 (1988), pp. 389-391;
37. G.P. Daston, "Do thresholds exist for developmental toxicants? A review of the experimental and theoretical evidence," H. Kalter, eds., in Issues and Reviews in Teratology, vol.6, pp 169-197 (New York: Plenum Press, 1993).
38. D. Crews et al., "Temperature-dependent sex determination in reptiles: Proximate mechanisms, ultimate outcomes, and practical applications," Developmental Genetics 15 (1994) pp. 297-312.
39. Ibid. D. Crews et al., "Temperature-dependent sex determination in reptiles: Proximate mechanisms, ultimate outcomes, and practical applications," Developmental Genetics 15 (1994) pp. 297-312.
40. R. Clarke, R.B. Dickson, and M.E. Lippman, "Hormonal aspects of breast cancer: Growth factors, drugs and stromal interactions," Critical Review of Oncology and Hematology 12 (1992), pp.1-23.
41. T.L.S. Tsai and Katzenellenbogen, "Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen RU 23,469 and effects on estrogen and progesterone receptors," Cancer Research 37 (1997), pp. 1537-1543
42. R.M. Sharpe and N.E. Skakkebaek, "Are oestrogens involved in falling sperm count and disorders of the male reproductive tract?" Lancet 341 (1993), pp. 1392-1395.
43. K.L Medlock, T.M. Forrester, and D.M. Sheehan, "Short-term effects of physiological and pharmacological doses of estradiol on estrogen receptor and uterine growth," Journal of Receptor Research 11 (1991), pp. 743-7;
44. K.L. Medlock et al., "Estradiol down-regulation of the rat uterine estrogen receptor," Proceedings of the Society for Experimental Biology and Medicine 196 (1991), pp. 293-300;
45. vom Saal et al., "Prostate enlargement in mice."
46. vom Saal et al, "Prostate enlargement in mice."
47. F.S. vom Saal, C.E. Finch, and J.F. Nelson, "Natural history and mechanisms of aging in humans, laboratory rodents and other selected vertebrates," in Physiology of Reproduction, E. Knobil, J. Neill and D. Pfaff, eds. (New York: Raven Press, 1994), pp. 1213-1313.
48. G.W. Lucier, C.J. Portier, and M.A. Gallo, "Receptor mechanisms and dose-response models for the effects of dioxins," Environmental Health Perspectives 101 (1993), pp. 36-44;
49. C.J. Portier et al. (1993), "Ligand/ receptor binding for 2,3,7,8-TCDD: Implications for risk assessment," Fundamental and Applied Toxicology 20 (1993), pp.48-56.
50. The opinions expressed here do not necessarily represent those of the Food and Drug Administration.